Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 CAD | 0.00% | +14.29% | 0.00% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Campbell
CEO | Chief Executive Officer | 53 | 25/11/20 |
Lyle Oberg
FOU | Founder | 63 | 05/07/18 |
Founder | 65 | 05/07/18 | |
Lih-Ming Tam
DFI | Director of Finance/CFO | - | - |
Chief Operating Officer | - | 08/03/22 | |
Iryna Saranchova
CTO | Chief Tech/Sci/R&D Officer | - | 14/05/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 65 | 05/07/18 | |
Lyle Oberg
FOU | Founder | 63 | 05/07/18 |
John Campbell
CEO | Chief Executive Officer | 53 | 25/11/20 |
Director/Board Member | 61 | 25/11/20 | |
Scott L. Nicoll
BRD | Director/Board Member | - | 27/10/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 24,358,625 | 9,785,852 ( 40.17 %) | 0 | 40.17 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
0.00% | 1.4M | |
+2.93% | 106B | |
+7.02% | 23.47B | |
-14.60% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.83% | 16.78B | |
+5.51% | 14.41B | |
+37.49% | 12.86B | |
+329.39% | 8.78B |
- Stock Market
- Equities
- MYND Stock
- Company MYND Life Sciences Inc.